Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fresenius Medical Care AG

This article was originally published in The Gray Sheet

Executive Summary

German dialysis product and service provider is "considering various financing options, mainly for further dialysis clinic acquisitions worldwide," according to a June 20 release. The operator of approximately 1,100 dialysis clinics in North America, Europe, Latin America and the Asia-Pacific region currently, Fresenius says it "has asked a banking consortium to investigate the placement of new preference shares to finance possible acquisitions." On June 23, the firm completed its acquisition of the 87 clinic facilities that make up the international and non-continental U.S. operations of DaVita, formerly known as Total Renal Care Holdings, for $145 mil., including $3 mil. in debt. A definitive agreement had been signed in January. Fresenius says it "will continue to pursue clinic acquisitions on a global basis that are financially accretive and located in markets that the company regards as strategically important"
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT013561

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel